The lab will increase the revenue to $4,000,0000 from the harvest
The lab will run all year round and process biomass for other farms
COCONUT CREEK, Fla., Nov. 07, 2018 (GLOBE NEWSWIRE) — via OTC PR WIRE — Global Consortium, Inc., (OTCPINK:BDCI) is pleased to announce the Company is building a processing lab in its 10,000 sq. ft. barn in Colorado.
A 2,000 sq. ft. section will be designated to convert the plants into CBD Isolate. Currently, the demand for CBD far outweighs its availability. Prices range from $7,500/kg to over $9,000/kg depending on the amount being purchased.
The biomass from the farm would have yielded around $950,000 to $1 million. With the addition of the lab, the same crop should yield $4,000,000 or more. The revenue will still show on the 4th quarter report.
Global will keep a portion of the Isolate for its own needs and sell the balance on the open market.
Building a lab for CBD in CO is an excellent choice since the crop is already located there. There are also additional CBD farms in the surrounding area that will need processing. The current license allows for the processing of the CBD into Isolate.
The lab added to the farm turns the farm into a multiple source of revenue streams: Biomass, CBD Isolate and 3rd party processing.
Bahamas Development Corporation, in compliance with SEC regulations, may in the future use social media outlets like Facebook or Twitter and its own website to announce key information in compliance with Reg. FD.
This news release contains “forward-looking statements” as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, estimates of services and equipment markets, release of corporate apps, growth of platform, target markets, product releases, product demand and, business strategy. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also consider that any investment in securities is at risk.
Details of the Company’s business, finances, appointments and agreements can be found as part of the Company’s continuous public disclosure on otcmarkets.com.
For additional information about this release please contact: